PS10 Late breaking Prophylactic use of quadrivalent human papillomavirus (HPV) (types 6, 11, 16, 18) L1 virus-like particle (VLP) vaccine reduces cervical intraepithelial neoplasia (CIN) 2/3 and adenocarcinoma in situ (AIS) risk
- 1 October 2005
- journal article
- abstracts
- Published by Elsevier in European Journal of Cancer Supplements
- Vol. 3 (4) , 11
- https://doi.org/10.1016/s1359-6349(05)82013-0
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: